Survival Rates


Capomulin preformed the best compared to Infubinol, Ketapril, and Placebo. The survival rate under Capomulin is far higher than the other drugs after the first 10 days. The average survival rate at 45 days under Capomulin is about 84%. The average survival rate at 45 days under Infubinol is 36% and the average survival rate under Ketapril and Placebo is 44%. Thus, after the duration of treatment, Capomulin had the highest survival rate and Infubinol had the lowest survival rate.

Visualizations


Tumor Responses Metastatic Spread Survival Rate Tumor Change